Exhibit 10.17
April 26, 2002
Lincoln Equity Research, LLC
0000 X. XxxXxxxxx Xxxx., Xxxxx 000
Xxxxx Xxx, XX 00000-0000
Attn: Xxxx Xxxxxx/Xxxx Xxxxxx
Gentlemen:
This letter will serve to confirm the agreement between Remedent USA, Inc.
(the "Company") and Lincoln Equity Research, LLC.
(1) Lincoln Equity Research, LLC hereby agrees to the receipt of 125,000 shares
of the Company's common stock in full repayment of the $10,000,
representing the outstanding accounts payable balance for investment
banking, research coverage and business analysis for the months of November
2001, December 2001, January 2002 and February 2002. Repayment is
calculated as the outstanding balance as of the date of this agreement, at
$0.08 per share.
(2) The Company hereby agrees to file for registration on an SB-2 Registration
Statement, the shares of common stock outlined in (1) above.
The above-mentioned terms are agreed upon on this day, by the following:
/s/ Xxxxxxx X. Xxxx /s/ Xxxx Xxxxxx /s/ Xxxx Xxxxxx
----------------------- -------------------------- --------------------------
Xxxxxxx X. Xxxx Xxxx Xxxxxx Xxxx Xxxxxx
Chief Financial Officer Managing Partner Managing Partner
Remedent USA, Inc. Lincoln Equity Research, LLC Lincoln Equity
Research, LLC
